The Civitan International Research Center’s mission is to improve the well-being and quality of life of individuals and families affected by intellectual and developmental disabilities.

For their continued research in sleep disorders in individuals with Down syndrome, UAB’s Caroline G. Richter, Ph.D. and S. Justin Thomas, Ph.D. were named the recipients of the 2024-2025 McNulty Civitan Scientist Award.

This finding suggests that therapy to remodel synapses could help memory in old age and dementia patients.

This devastating neurodevelopmental disorder has no currently approved treatments.

The new, five-year grant will support research in the UAB Alzheimer’s Disease Research Center to address dementia disparities in the Deep South.

The drug appears to help strengthen pathways in the brain, improving the ability of neurons to communicate with each other.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

Part of the mission of the Civitan International Research Center is to foster the next generation of scientists studying brain development.

A mouse model and previous studies suggest that genetic intervention in SHANK3-related ASD may be most effective earlier in development.